Loading…

ROS mediated antibacterial activity of photoilluminated riboflavin: A photodynamic mechanism against nosocomial infections

•Riboflavin undergoes intersystem conversion under photoillumination.•Interacts with molecular oxygen and generates ROS.•Generated ROS disrupts E. coli cell membranes.•Ultimately killing E. coli.•Mechanism can be used to kill E. coli on hospital ware causing nosocomial infections. Nosocomial infecti...

Full description

Saved in:
Bibliographic Details
Published in:Toxicology reports 2019-01, Vol.6, p.136-142
Main Authors: Khan, Saniyya, P, Mohammed Rayis, Rizvi, Asim, Alam, Md. Maroof, Rizvi, Meher, Naseem, Imrana
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c595t-b146ddcea0d09afe2380ffeda5b278c6351eaf42bd8c3e29ed74a100ebe9a31b3
cites cdi_FETCH-LOGICAL-c595t-b146ddcea0d09afe2380ffeda5b278c6351eaf42bd8c3e29ed74a100ebe9a31b3
container_end_page 142
container_issue
container_start_page 136
container_title Toxicology reports
container_volume 6
creator Khan, Saniyya
P, Mohammed Rayis
Rizvi, Asim
Alam, Md. Maroof
Rizvi, Meher
Naseem, Imrana
description •Riboflavin undergoes intersystem conversion under photoillumination.•Interacts with molecular oxygen and generates ROS.•Generated ROS disrupts E. coli cell membranes.•Ultimately killing E. coli.•Mechanism can be used to kill E. coli on hospital ware causing nosocomial infections. Nosocomial infections are a major threat to modern therapeutics. The major causative agent of these infections is multidrug-resistant gram-negative bacteria, which impart high morbidity and mortality rate. This has led to an urge for the development of new antibiotics. Antimicrobial photodynamic therapy is a promising strategy to which till date no resistant strain has been reported. Since the efficacy of photodynamic therapy largely depends on the selection and administration of an appropriate photosensitizer, therefore, the realization of clinically active photosensitizers is an immediate need. Here, by using E. coli as a study model we have demonstrated the antimicrobial photodynamic potential of riboflavin. Intracellular ROS formation by DCFH-DA assay, lipid peroxidation, protein carbonylation, LDH activity was measured in treated bacterial samples. Enzymatic (SOD, CAT, GSH) antioxidants and non-enzymatic (GSH) was further evaluated. Bacterial death was confirmed by colony forming assay, optical microscopy and scanning electron microscopy. The treated bacterial cells exhibited abundant ROS generation and marked increment in the level of oxidative stress markers as well as significant reduction in LDH activity. Marked reduction in colony forming units was also observed. Optical microscopic and SEM images further confirmed the bacterial death. Thus, we can say that photoilluminated riboflavin renders the redox status of bacterial cells into a compromised state leading to significant membrane damage ultimately causing bacterial death. This study aims to add one more therapeutic dimension to photoilluminated riboflavin as it can be effectively employed in targeting bacterial biofilms occurring on hospital wares causing several serious medical conditions.
doi_str_mv 10.1016/j.toxrep.2019.01.003
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_87155ef40a8a4c0f94c3d8f16c79fe84</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2214750018306553</els_id><doaj_id>oai_doaj_org_article_87155ef40a8a4c0f94c3d8f16c79fe84</doaj_id><sourcerecordid>2179426286</sourcerecordid><originalsourceid>FETCH-LOGICAL-c595t-b146ddcea0d09afe2380ffeda5b278c6351eaf42bd8c3e29ed74a100ebe9a31b3</originalsourceid><addsrcrecordid>eNp9kktrGzEQx5fS0oQ036CUPfZid_TaRw-FEPoIBAJ9nMWsNLJldiVXWpumn75ynKbJpScNmv_8Rpr5V9VrBksGrHm3Wc7xV6LtkgPrl8CWAOJZdco5k4tWATx_FJ9U5zlvAIBx1YCSL6sTAU3LhOxPq99fb77VE1mPM9kaw-wHNDMlj2NdAr_3820dXb1dxzn6cdxNPtxJkx-iG3Hvw_v64pi2twEnbwrOrDH4PNW4Qh_yXIeYo4nTAeqDo8KNIb-qXjgcM53fn2fVj08fv19-WVzffL66vLheGNWreTEw2VhrCMFCj4646MA5sqgG3namEYoROskH2xlBvCfbSmQANFCPgg3irLo6cm3Ejd4mP2G61RG9vruIaaUxzd6MpLuWKUVOAnYoDbheGmE7xxrT9o46WVgfjqztbihTMxTmhOMT6NNM8Gu9invdCAFKtQXw9h6Q4s8d5VlPPhsaRwwUd1lz1vaSN7xrilQepSbFnBO5hzYM9MEFeqOPLtAHF2hguriglL15_MSHor87__cHKkPfe0o6G0_BFBOkspoyFf__Dn8AhTjKlQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2179426286</pqid></control><display><type>article</type><title>ROS mediated antibacterial activity of photoilluminated riboflavin: A photodynamic mechanism against nosocomial infections</title><source>ScienceDirect Additional Titles</source><source>PubMed Central</source><creator>Khan, Saniyya ; P, Mohammed Rayis ; Rizvi, Asim ; Alam, Md. Maroof ; Rizvi, Meher ; Naseem, Imrana</creator><creatorcontrib>Khan, Saniyya ; P, Mohammed Rayis ; Rizvi, Asim ; Alam, Md. Maroof ; Rizvi, Meher ; Naseem, Imrana</creatorcontrib><description>•Riboflavin undergoes intersystem conversion under photoillumination.•Interacts with molecular oxygen and generates ROS.•Generated ROS disrupts E. coli cell membranes.•Ultimately killing E. coli.•Mechanism can be used to kill E. coli on hospital ware causing nosocomial infections. Nosocomial infections are a major threat to modern therapeutics. The major causative agent of these infections is multidrug-resistant gram-negative bacteria, which impart high morbidity and mortality rate. This has led to an urge for the development of new antibiotics. Antimicrobial photodynamic therapy is a promising strategy to which till date no resistant strain has been reported. Since the efficacy of photodynamic therapy largely depends on the selection and administration of an appropriate photosensitizer, therefore, the realization of clinically active photosensitizers is an immediate need. Here, by using E. coli as a study model we have demonstrated the antimicrobial photodynamic potential of riboflavin. Intracellular ROS formation by DCFH-DA assay, lipid peroxidation, protein carbonylation, LDH activity was measured in treated bacterial samples. Enzymatic (SOD, CAT, GSH) antioxidants and non-enzymatic (GSH) was further evaluated. Bacterial death was confirmed by colony forming assay, optical microscopy and scanning electron microscopy. The treated bacterial cells exhibited abundant ROS generation and marked increment in the level of oxidative stress markers as well as significant reduction in LDH activity. Marked reduction in colony forming units was also observed. Optical microscopic and SEM images further confirmed the bacterial death. Thus, we can say that photoilluminated riboflavin renders the redox status of bacterial cells into a compromised state leading to significant membrane damage ultimately causing bacterial death. This study aims to add one more therapeutic dimension to photoilluminated riboflavin as it can be effectively employed in targeting bacterial biofilms occurring on hospital wares causing several serious medical conditions.</description><identifier>ISSN: 2214-7500</identifier><identifier>EISSN: 2214-7500</identifier><identifier>DOI: 10.1016/j.toxrep.2019.01.003</identifier><identifier>PMID: 30671349</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Antibacterial ; Nosocomial infection ; Photodynamic therapy ; Riboflavin ; ROS</subject><ispartof>Toxicology reports, 2019-01, Vol.6, p.136-142</ispartof><rights>2019 The Authors</rights><rights>2019 The Authors. Published by Elsevier B.V. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c595t-b146ddcea0d09afe2380ffeda5b278c6351eaf42bd8c3e29ed74a100ebe9a31b3</citedby><cites>FETCH-LOGICAL-c595t-b146ddcea0d09afe2380ffeda5b278c6351eaf42bd8c3e29ed74a100ebe9a31b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330557/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2214750018306553$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30671349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khan, Saniyya</creatorcontrib><creatorcontrib>P, Mohammed Rayis</creatorcontrib><creatorcontrib>Rizvi, Asim</creatorcontrib><creatorcontrib>Alam, Md. Maroof</creatorcontrib><creatorcontrib>Rizvi, Meher</creatorcontrib><creatorcontrib>Naseem, Imrana</creatorcontrib><title>ROS mediated antibacterial activity of photoilluminated riboflavin: A photodynamic mechanism against nosocomial infections</title><title>Toxicology reports</title><addtitle>Toxicol Rep</addtitle><description>•Riboflavin undergoes intersystem conversion under photoillumination.•Interacts with molecular oxygen and generates ROS.•Generated ROS disrupts E. coli cell membranes.•Ultimately killing E. coli.•Mechanism can be used to kill E. coli on hospital ware causing nosocomial infections. Nosocomial infections are a major threat to modern therapeutics. The major causative agent of these infections is multidrug-resistant gram-negative bacteria, which impart high morbidity and mortality rate. This has led to an urge for the development of new antibiotics. Antimicrobial photodynamic therapy is a promising strategy to which till date no resistant strain has been reported. Since the efficacy of photodynamic therapy largely depends on the selection and administration of an appropriate photosensitizer, therefore, the realization of clinically active photosensitizers is an immediate need. Here, by using E. coli as a study model we have demonstrated the antimicrobial photodynamic potential of riboflavin. Intracellular ROS formation by DCFH-DA assay, lipid peroxidation, protein carbonylation, LDH activity was measured in treated bacterial samples. Enzymatic (SOD, CAT, GSH) antioxidants and non-enzymatic (GSH) was further evaluated. Bacterial death was confirmed by colony forming assay, optical microscopy and scanning electron microscopy. The treated bacterial cells exhibited abundant ROS generation and marked increment in the level of oxidative stress markers as well as significant reduction in LDH activity. Marked reduction in colony forming units was also observed. Optical microscopic and SEM images further confirmed the bacterial death. Thus, we can say that photoilluminated riboflavin renders the redox status of bacterial cells into a compromised state leading to significant membrane damage ultimately causing bacterial death. This study aims to add one more therapeutic dimension to photoilluminated riboflavin as it can be effectively employed in targeting bacterial biofilms occurring on hospital wares causing several serious medical conditions.</description><subject>Antibacterial</subject><subject>Nosocomial infection</subject><subject>Photodynamic therapy</subject><subject>Riboflavin</subject><subject>ROS</subject><issn>2214-7500</issn><issn>2214-7500</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kktrGzEQx5fS0oQ036CUPfZid_TaRw-FEPoIBAJ9nMWsNLJldiVXWpumn75ynKbJpScNmv_8Rpr5V9VrBksGrHm3Wc7xV6LtkgPrl8CWAOJZdco5k4tWATx_FJ9U5zlvAIBx1YCSL6sTAU3LhOxPq99fb77VE1mPM9kaw-wHNDMlj2NdAr_3820dXb1dxzn6cdxNPtxJkx-iG3Hvw_v64pi2twEnbwrOrDH4PNW4Qh_yXIeYo4nTAeqDo8KNIb-qXjgcM53fn2fVj08fv19-WVzffL66vLheGNWreTEw2VhrCMFCj4646MA5sqgG3namEYoROskH2xlBvCfbSmQANFCPgg3irLo6cm3Ejd4mP2G61RG9vruIaaUxzd6MpLuWKUVOAnYoDbheGmE7xxrT9o46WVgfjqztbihTMxTmhOMT6NNM8Gu9invdCAFKtQXw9h6Q4s8d5VlPPhsaRwwUd1lz1vaSN7xrilQepSbFnBO5hzYM9MEFeqOPLtAHF2hguriglL15_MSHor87__cHKkPfe0o6G0_BFBOkspoyFf__Dn8AhTjKlQ</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Khan, Saniyya</creator><creator>P, Mohammed Rayis</creator><creator>Rizvi, Asim</creator><creator>Alam, Md. Maroof</creator><creator>Rizvi, Meher</creator><creator>Naseem, Imrana</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20190101</creationdate><title>ROS mediated antibacterial activity of photoilluminated riboflavin: A photodynamic mechanism against nosocomial infections</title><author>Khan, Saniyya ; P, Mohammed Rayis ; Rizvi, Asim ; Alam, Md. Maroof ; Rizvi, Meher ; Naseem, Imrana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c595t-b146ddcea0d09afe2380ffeda5b278c6351eaf42bd8c3e29ed74a100ebe9a31b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Antibacterial</topic><topic>Nosocomial infection</topic><topic>Photodynamic therapy</topic><topic>Riboflavin</topic><topic>ROS</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khan, Saniyya</creatorcontrib><creatorcontrib>P, Mohammed Rayis</creatorcontrib><creatorcontrib>Rizvi, Asim</creatorcontrib><creatorcontrib>Alam, Md. Maroof</creatorcontrib><creatorcontrib>Rizvi, Meher</creatorcontrib><creatorcontrib>Naseem, Imrana</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Toxicology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khan, Saniyya</au><au>P, Mohammed Rayis</au><au>Rizvi, Asim</au><au>Alam, Md. Maroof</au><au>Rizvi, Meher</au><au>Naseem, Imrana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ROS mediated antibacterial activity of photoilluminated riboflavin: A photodynamic mechanism against nosocomial infections</atitle><jtitle>Toxicology reports</jtitle><addtitle>Toxicol Rep</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>6</volume><spage>136</spage><epage>142</epage><pages>136-142</pages><issn>2214-7500</issn><eissn>2214-7500</eissn><abstract>•Riboflavin undergoes intersystem conversion under photoillumination.•Interacts with molecular oxygen and generates ROS.•Generated ROS disrupts E. coli cell membranes.•Ultimately killing E. coli.•Mechanism can be used to kill E. coli on hospital ware causing nosocomial infections. Nosocomial infections are a major threat to modern therapeutics. The major causative agent of these infections is multidrug-resistant gram-negative bacteria, which impart high morbidity and mortality rate. This has led to an urge for the development of new antibiotics. Antimicrobial photodynamic therapy is a promising strategy to which till date no resistant strain has been reported. Since the efficacy of photodynamic therapy largely depends on the selection and administration of an appropriate photosensitizer, therefore, the realization of clinically active photosensitizers is an immediate need. Here, by using E. coli as a study model we have demonstrated the antimicrobial photodynamic potential of riboflavin. Intracellular ROS formation by DCFH-DA assay, lipid peroxidation, protein carbonylation, LDH activity was measured in treated bacterial samples. Enzymatic (SOD, CAT, GSH) antioxidants and non-enzymatic (GSH) was further evaluated. Bacterial death was confirmed by colony forming assay, optical microscopy and scanning electron microscopy. The treated bacterial cells exhibited abundant ROS generation and marked increment in the level of oxidative stress markers as well as significant reduction in LDH activity. Marked reduction in colony forming units was also observed. Optical microscopic and SEM images further confirmed the bacterial death. Thus, we can say that photoilluminated riboflavin renders the redox status of bacterial cells into a compromised state leading to significant membrane damage ultimately causing bacterial death. This study aims to add one more therapeutic dimension to photoilluminated riboflavin as it can be effectively employed in targeting bacterial biofilms occurring on hospital wares causing several serious medical conditions.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>30671349</pmid><doi>10.1016/j.toxrep.2019.01.003</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2214-7500
ispartof Toxicology reports, 2019-01, Vol.6, p.136-142
issn 2214-7500
2214-7500
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_87155ef40a8a4c0f94c3d8f16c79fe84
source ScienceDirect Additional Titles; PubMed Central
subjects Antibacterial
Nosocomial infection
Photodynamic therapy
Riboflavin
ROS
title ROS mediated antibacterial activity of photoilluminated riboflavin: A photodynamic mechanism against nosocomial infections
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T17%3A57%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ROS%20mediated%20antibacterial%20activity%20of%20photoilluminated%20riboflavin:%20A%20photodynamic%20mechanism%20against%20nosocomial%20infections&rft.jtitle=Toxicology%20reports&rft.au=Khan,%20Saniyya&rft.date=2019-01-01&rft.volume=6&rft.spage=136&rft.epage=142&rft.pages=136-142&rft.issn=2214-7500&rft.eissn=2214-7500&rft_id=info:doi/10.1016/j.toxrep.2019.01.003&rft_dat=%3Cproquest_doaj_%3E2179426286%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c595t-b146ddcea0d09afe2380ffeda5b278c6351eaf42bd8c3e29ed74a100ebe9a31b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2179426286&rft_id=info:pmid/30671349&rfr_iscdi=true